This company listing is no longer active
D840 Stock Overview
Bloom Health Partners Inc. delivers health care solutions in Canada, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Bloom Health Partners Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.029 |
| 52 Week High | CA$0.24 |
| 52 Week Low | CA$0.029 |
| Beta | -1.81 |
| 11 Month Change | 0% |
| 3 Month Change | -20.55% |
| 1 Year Change | -86.32% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| D840 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | -0.6% |
| 1Y | -86.3% | 19.3% | 9.6% |
Return vs Industry: D840 underperformed the German Healthcare industry which returned -33.2% over the past year.
Return vs Market: D840 underperformed the German Market which returned -9.5% over the past year.
Price Volatility
| D840 volatility | |
|---|---|
| D840 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: D840's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine D840's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.bloomhealthpartners.com |
Bloom Health Partners Inc. delivers health care solutions in Canada, the United States, and internationally. It offers COVID-19 testing solutions, such as RT-PCR and point-of-care rapid testing, as well as RT-PCR mail-in-kits. The company was formerly known as Maitri Health Technologies Corp.and changed its name to Bloom Health Partners Inc. in October 2021.
Bloom Health Partners Inc. Fundamentals Summary
| D840 fundamental statistics | |
|---|---|
| Market cap | €2.65m |
| Earnings (TTM) | €2.49m |
| Revenue (TTM) | €24.20m |
1.1x
P/E Ratio0.1x
P/S RatioIs D840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| D840 income statement (TTM) | |
|---|---|
| Revenue | CA$34.81m |
| Cost of Revenue | CA$13.71m |
| Gross Profit | CA$21.09m |
| Other Expenses | CA$17.51m |
| Earnings | CA$3.58m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.075 |
| Gross Margin | 60.60% |
| Net Profit Margin | 10.28% |
| Debt/Equity Ratio | 0% |
How did D840 perform over the long term?
See historical performance and comparison